All Facilities , From 2026-11-02 - 2026-11-22
Resistance isolates
339
AST results tested
3,582
Overall resistance
41.4%
Highest rate
Ceftizoxime (100.0%)
n = 339 Number of Isolates
All Specimens All Organisms
n = 339 Number of Isolates
All Specimens All Organisms
| Antibiotic | Total Tested | Number Resistance | % Resistance |
|---|---|---|---|
| Ceftizoxime | 1 | 1 | 100.0 |
| Benzylpenicillin | 5 | 5 | 100.0 |
| Ampicillin/Sulbactum | 1 | 1 | 100.0 |
| Micafungin | 3 | 3 | 100.0 |
| Caspofungin | 3 | 3 | 100.0 |
| NYSTATIN | 4 | 4 | 100.0 |
| Ketoconazole | 4 | 4 | 100.0 |
| Cefazolin | 14 | 13 | 92.9 |
| Penicillin G | 45 | 40 | 88.9 |
| Ampicillin | 67 | 54 | 80.6 |
| Oxacillin | 20 | 16 | 80.0 |
| Cefuroxime | 99 | 78 | 78.8 |
| Cefotaxime | 54 | 41 | 75.9 |
| ITRACONAZOLE | 4 | 3 | 75.0 |
| Ceftriaxone | 177 | 130 | 73.4 |
| Erythromycin | 82 | 56 | 68.3 |
| azithromycin | 22 | 15 | 68.2 |
| Amoxicillin | 3 | 2 | 66.7 |
| Aztreonem | 3 | 2 | 66.7 |
| Trimethoprim | 15 | 10 | 66.7 |
| aztreonam | 9 | 6 | 66.7 |
| Trimethoprim/Sulfamethoxazole | 244 | 150 | 61.5 |
| Tetracycline | 101 | 57 | 56.4 |
| Ciprofloxacin | 250 | 140 | 56.0 |
| Ceftazidime | 173 | 88 | 50.9 |
| Ampicillin/ Sulbactam | 45 | 21 | 46.7 |
| Amoxicillin/ Clavulanic acid | 99 | 43 | 43.4 |
| Levofloxacin | 144 | 62 | 43.1 |
| FLUCONAZOLE | 7 | 3 | 42.9 |
| Gentamicin | 267 | 110 | 41.2 |
| Cefepime | 151 | 60 | 39.7 |
| Tobramycin | 26 | 10 | 38.5 |
| Doxycycline | 34 | 13 | 38.2 |
| Rifampin | 21 | 8 | 38.1 |
| Cefoxitin | 66 | 25 | 37.9 |
| Nalidixic acid | 33 | 12 | 36.4 |
| Clindamycin | 78 | 27 | 34.6 |
| Piperacillin | 3 | 1 | 33.3 |
| Ertapenem | 21 | 6 | 28.6 |
| Moxifloxacin | 19 | 5 | 26.3 |
| Nitrofurantoin | 118 | 27 | 22.9 |
| Piperacillin/Tazobactam | 210 | 43 | 20.5 |
| Amoxicillin/Clavulanic acid | 5 | 1 | 20.0 |
| Teicoplanin | 11 | 2 | 18.2 |
| Doxycline | 6 | 1 | 16.7 |
| Meropenem | 192 | 24 | 12.5 |
| Imipenem | 182 | 22 | 12.1 |
| Chloramphenicol | 75 | 8 | 10.7 |
| Vancomycin | 75 | 8 | 10.7 |
| Amikacin | 143 | 13 | 9.1 |